1. Home
  2. RKDA vs VRAX Comparison

RKDA vs VRAX Comparison

Compare RKDA & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arcadia Biosciences Inc.

RKDA

Arcadia Biosciences Inc.

N/A

Current Price

$0.16

Market Cap

1.1M

Sector

Industrials

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

N/A

Current Price

$1.32

Market Cap

972.3K

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RKDA
VRAX
Founded
2002
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
972.3K
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
RKDA
VRAX
Price
$0.16
$1.32
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 573.5K
152.5K
Earning Date
11-10-2026
11-20-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 66.92
N/A
EPS
N/A
★ N/A
Revenue
★ $4,858,000.00
N/A
Revenue This Year
$58.50
N/A
Revenue Next Year
$475.01
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.11
$0.10
52 Week High
$8.36
$13.19

Technical Indicators

Market Signals
Indicator
RKDA
VRAX
Relative Strength Index (RSI) 24.64 28.53
Support Level $0.11 $0.15
Resistance Level $0.31 $2.92
Average True Range (ATR) 0.03 0.15
MACD 0.02 -0.01
Stochastic Oscillator 35.77 21.07

Price Performance

Historical Comparison
RKDA
VRAX

About RKDA Arcadia Biosciences Inc.

Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the detection of immune responses and the development of immune profiling and in vitro diagnostic technologies for viral and immune-mediated diseases, with a current strategic focus on post-acute infection syndromes (PAIS) and related areas of chronic immune dysfunction. The company's principal development activities are centered on T cell-based in vitro diagnostics and immune profiling. The company's flagship product candidate, ViraxImmune, is an in-development T cell-based assay and immune profiling platform intended to support the assessment of immune dysfunction, initially in PAIS indications.

Share on Social Networks: